Hepatocellular Carcinoma

The management of hepatocellular carcinoma often involves immune checkpoint inhibitor therapy, which can result in significant hepatic immune-related adverse events. Fillmore and his collaborators developed a rule-based algorithm to identify moderate to severe liver toxicity in these patients. This tool provides a more accurate method for detecting adverse events than individual clinical review, facilitating the analysis of liver toxicity within large patient cohorts.